Andere talen Ekso Bionics Holdings, Inc.

Aandelen

EKSO

US2826443010

Geschatte realtime Cboe BZX Andere beurzen 16:10:32 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,34 ^USD	+3,88%		+11,21%	-48,40%

29/04	Transcript : Ekso Bionics Holdings, Inc., Q1 2024 Earnings Call, Apr 29, 2024
29/04	Ekso Bionics Holdings, Inc. Rapporteert de winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ekso Bionics: Q1 Earnings Snapshot	29/04
Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Posts Q1 Revenue $3.8M, vs. Street Est of $5M	29/04
Ekso Bionics Announces First Quarter 2024 Financial Results	29/04
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024	22/04
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal	12/04
Certain Warrants of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	17/03
Certain Common Stock of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	17/03
Ekso Bionics: Q4 Earnings Snapshot	04/03
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/03
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04/03
Ekso Bionics Reports Record Annual Revenue of $18.3 Million	04/03
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024	26/02
Ekso Bionics Announces $4.6 Million Registered Direct Offering	11/01
Ekso Bionics Launches GaitCoach Software for EksoNR	08/01
Ekso Bionics Holdings, Inc. Launches GaitCoach Software for EksoNR	08/01
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results	04/01
Ekso Bionics Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023	04/01
Ekso Bionics : Investor Presentation	18/12
Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal	12/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ekso Bionics Holdings, Inc.

Aandelen

EKSO

US2826443010

Andere talen

Filters